SSB 5388: Concerning improving diversity in clinical trials.
Did not pass. The 2023-24 session has ended.
- Sponsor
- Rivers
- Introduced
- January 16, 2023
- Status
- S Rules X
- Last action
- Senate Rules "X" file. (January 8, 2024)
- As of
- August 18, 2026, 2:03 AM Pacific, from the Legislature’s records
What this bill does
Requires the Washington State Institutional Review Board to establish a diversity in clinical trials program. Requires any state entity receiving funding from the National Institutes of Health to conduct clinical trials of drugs or medical devices to adopt a policy to identify and recruit persons who are members of underrepresented demographic groups.
From the Washington State Legislature's nonpartisan staff bill analysis. Read the full analysis ↗
Floor votes
- Senate: 3rd Reading & Final Passage · March 6, 202348 yea · 0 nay · 1 not voting
Track SSB 5388 on OlympiaTrack
A free account adds the full hearing and amendment record, who testified, roll calls by member, and a list to track it on. Paid plans add a plain-English AI summary and an alert if its subject comes back next session.
Create a free accountOther bills sponsored by Rivers
- SB 5069: Allowing interstate cannabis agreements.
- SB 5163: Removing the sunset provisions on the medicaid fraud false claims act.
- SB 5184: Concerning licensure of anesthesiologist assistants.
- SSB 5377: Concerning cannabis license ownership.
- SSB 5569: Creating exemptions from certificate of need requirements for kidney disease centers.
All 2023-24 Washington State bills →
Source: the Washington State Legislature. OlympiaTrack is an independent bill-tracking service and is not affiliated with the Legislature. View on leg.wa.gov ↗